Spearhead Capital Advisors, LLC Bluebird Bio, Inc. Transaction History

Spearhead Capital Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 28, 2022	SELL	$4.07 - $10.6 $59,458 - $154,855	-14,609 Closed	0 $0
Q4 2021 Jan 25, 2022	BUY	$8.96 - $16.31 $12,821 - $23,339	1,431 Added 10.86%	14,609 $146,000
Q3 2021 Oct 27, 2021	BUY	$11.24 - $21.0 $10,779 - $20,139	959 Added 7.85%	13,178 $252,000
Q2 2021 Aug 10, 2021	BUY	$18.04 - $22.09 $27,943 - $34,217	1,549 Added 14.52%	12,219 $391,000
Q1 2021 Apr 28, 2021	BUY	$16.59 - $33.89 $177,015 - $361,606	10,670 New	10,670 $322,000

151

63.4M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $28.5M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Spearhead Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Spearhead Capital Advisors, LLC with notifications on news.